Ampio Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for prevalent inflammatory conditions for which limited treatment options exist. We are advancing immunology-based therapies to provide safe and effective treatments for patients suffering from these diseases.
Our lead product, Ampion, is a biologic drug that uses the power of the immune response to address the underlying causes of inflammatory disease. Ampion is designed to provide anti-inflammatory relief to safely treat persistent inflammation and improve the lives of people with debilitating diseases, like osteoarthritis, respiratory illness, and other inflammatory conditions.
Our lead product, Ampion, is a biologic drug that uses the power of the immune response to address the underlying causes of inflammatory disease. Ampion is designed to provide anti-inflammatory relief to safely treat persistent inflammation and improve the lives of people with debilitating diseases, like osteoarthritis, respiratory illness, and other inflammatory conditions.
Services
Ampio Pharmaceuticals is an innovative drug discovery and development company combining scientific, clinical, and manufacturing capabilities to develop novel immunology-based therapies aimed at treating prevalent inflammatory conditions for which limited treatment options exist. Ampio's therapeutic product pipeline is the result of more than two decades of research at leading hospital-based research centers.
Our management team has a proven track record of successfully developing and commercializing pharmaceuticals while maintaining a distinct focus on efficient, entrepreneurial business processes. Michael Macaluso founded DMI Life Sciences, Inc., our predecessor, and has been a member of the board of directors of DMI Life Sciences, Inc. since its inception.
Our board of directors has a broad range of expertise in pharmaceuticals, diagnostics, and medical devices across product development, executive and financial management, commercialization, and corporate development. Michael Macaluso founded DMI Life Sciences, Inc., our predecessor, and has been a member of the board of directors of DMI Life Sciences, Inc. since its inception.
Ampio operates a modern, state-of-the-art facility to support clinical supply, product/process development, and the long-term commercial production of Ampion. The facility meets international regulatory compliance standards and has the capacity to support global demand. Our research, manufacturing, and quality teams play an important role in every phase of Ampion development, from product and process development to manufacturing and distribution.
Reviews
Be the first to review Ninth Floor.
Write a Review
